Related references
Note: Only part of the references are listed.Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome
Rishi R. Goel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3
Kay Tanita et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype
Laura Faletti et al.
BIOMEDICAL JOURNAL (2021)
Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance
Takaki Asano et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity
Sabine Jaegle et al.
CLINICAL IMMUNOLOGY (2020)
Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review
Alexandre Fabre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Th17 cells in primary Sjogren's syndrome: Pathogenicity and plasticity
Gwenny M. Verstappen et al.
JOURNAL OF AUTOIMMUNITY (2018)
Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia
Toru Kawakami et al.
BLOOD ADVANCES (2018)
The Ying and Yang of STAT3 in Human Disease
Tiphanie P. Vogel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function
Robert P. Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Th17 cells play a critical role in the development of experimental Sjogren's syndrome
Xiang Lin et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3
Emma M. Haapaniemi et al.
BLOOD (2015)
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Joshua D. Milner et al.
BLOOD (2015)
Eight color immunophenotyping of T-, B- and NK-cell subpopulations for characterization of chronic immunodeficiencies
Boldt A et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2014)
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Sarah E. Flanagan et al.
NATURE GENETICS (2014)
IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts
Lucinda J. Berglund et al.
BLOOD (2013)
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T-cell memory formation and function
Megan L. Ives et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Functional STAT3 deficiency compromises the generation of human T follicular helper cells
Cindy S. Ma et al.
BLOOD (2012)
Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation
Almut Meyer-Bahlburg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome Molecular, Cellular, and Clinical Features From a French National Survey
Marie-Olivia Chandesris et al.
MEDICINE (2012)
Paediatric Reference Values for the Peripheral T cell Compartment
E. J. H. Schatorje et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory
Andrea M. Siegel et al.
IMMUNITY (2011)
Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells
Masako Saito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome
Cristina Woellner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans
Danielle T. Avery et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome
Ellen D. Renner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Cindy S. Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjogren's syndrome
H. L. Ramos et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
Share Paper
